EYPT — Eyepoint Pharmaceuticals Inc · rev $1.2M

Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.

Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.

Use this EYPT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EYPT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EYPT SEC filings page. Lician reads the product cache first so this HTML stays unique to Eyepoint Pharmaceuticals Inc even when a live quote feed is slow.